Health Canada drug identification number

DIN 02539764 — TECVAYLI 153 MG

TECVAYLI is a solution of Teclistamab marketed by JANSSEN INC. The full Teclistamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02539764
Brand name
TECVAYLI
Active ingredient
Teclistamab
Strength
153 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
JANSSEN INC
Health Canada status
MARKETED
Drug class
Bispecific T-cell engager (BCMA x CD3 bispecific antibody)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Teclistamab products

DINBrandStrengthFormManufacturerStatus
02539756 TECVAYLI 30 MG SOLUTION JANSSEN INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.